<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1003257018
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2025
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Salofalk
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MESALAZINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1500
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release granules
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        60
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Sachet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        48
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        238.15
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="LOSAN PHARMA GMBH " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            LOSAN PHARMA GMBH 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            DR. FALK PHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A07EC02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Salofalk granules contain the active substance mesalazine, an anti-inflammatory agent used to treat inflammatory bowel disease.</p><p>&nbsp;</p><p>Salofalk 1500 mg granules are used for:</p><p>-&nbsp;&nbsp; &nbsp;&nbsp; the treatment of acute episodes and prevention of further episodes (recurrence) of an inflammatory disease of the large intestine (colon), known by doctors as ulcerative colitis.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not take Salofalk granules</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic to mesalazine, salicylic acid, salicylates such as Aspirin or any of the other ingredients of this medicine (listed in section 6).</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a serious liver or kidney disease.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor before taking Salofalk 1500&nbsp;mg granules<br />&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a history of problems with your lungs, particularly if you suffer from <strong>bronchial asthma</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have a <strong>history of allergy to sulphasalazine</strong>,<strong> </strong>a substance related to mesalazine</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer with problems of your <strong>liver</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer with problems of your <strong>kidney</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have ever developed a severe skin rash or skin peeling, blistering and/or mouth sores after using mesazaline</p><p>&nbsp;</p><p>Mesalazine may produce red-brown urine discoloration after contact with sodium hypochlorite bleach in the toilet water. It concerns a chemical reaction between mesalazine and bleach and is harmless.</p><p>&nbsp;</p><p>Further precautions</p><p>During treatment your doctor may want to keep you under close medical supervision and you may need to have regular blood and urine tests.</p><p>&nbsp;</p><p>Kidney stones may develop with use of mesalazine. Symptoms may include pain in sides of abdomen and blood in urine. Take care to drink sufficient amount of liquid during treatment with mesalazine.<br />&nbsp;</p><p>Serious skin reactions including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have been reported in association with mesalazine treatment. Stop using mesalazine</p><p>and seek medical attention immediately if you notice any of the symptoms related to these serious skin reactions described in section 4.</p><p>&nbsp;</p><p>Other medicines and Salofalk granules</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, in particular:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Azathioprine, 6-mercaptopurine or thioguanine </strong>(medicines used to treat immune disorders)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Certain agents that inhibit blood clotting </strong>(medicines for thrombosis or to thin your blood, e.g. warfarin)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Lactulose </strong>(medicine used to treat constipation) or <strong>other preparations that can change the acidity of your stools</strong></p><p>&nbsp;</p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. It may still be all right for you to use Salofalk granules and your doctor will be able to decide what is suitable for you.</p><p>&nbsp;</p><p><strong>Pregnancy and breastfeeding</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p>You should only use Salofalk granules during pregnancy if your doctor tells you to.</p><p>&nbsp;</p><p>You should also only use Salofalk granules during breastfeeding if your doctor tells you to, as this medicine may pass into breast milk.</p><p>&nbsp;</p><p>Driving and using machines</p><p>Salofalk granules have no or negligible influence on the ability to drive or use machines.</p><p>&nbsp;</p><p><strong>Salofalk 1500&nbsp;mg granules contain aspartame, sucrose and sodium</strong></p><p>This medicine contains 3&nbsp;mg aspartame in each sachet of Salofalk 1500&nbsp;mg granules. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.</p><p>&nbsp;</p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.</p><p>&nbsp;</p><p>This medicine contains less than 1 mmol sodium (23 mg) per sachet, that is to say essentially &lsquo;sodium-free&rsquo;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take Salofalk granules exactly as your doctor has told you. &nbsp;Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p><strong>Method of administration</strong></p><p><strong>&nbsp;</strong></p><p>Salofalk granules are for oral use only.</p><p>Salofalk granules should <strong>not be chewed</strong>. &nbsp;You should take the Salofalk granules by placing the granules directly on the tongue and then swallowing them with plenty of liquid without chewing.</p><p>&nbsp;</p><p>Dosage</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:618px"><tbody><tr><td style="vertical-align:top"><p>Age and body weight</p></td><td style="vertical-align:top"><p>Single dose</p></td><td style="vertical-align:top"><p>Total daily dose</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Adults, elderly and children</p><p>weighing more than 40&nbsp;kg</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Treatment of acute episodes</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>Up to 2 sachets Salofalk 1500&nbsp;mg granules</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1 x 1-2 sachets</p><p>&nbsp;</p><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p><p>Prevention of further episodes</p><p>(for patients at increased risk for recurrence)</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>2 sachets Salofalk 1500&nbsp;mg</p><p>granules</p></td><td style="vertical-align:top"><p>&nbsp;</p><p>1 x 2 sachets</p><p>&nbsp;</p></td></tr></tbody></table><p>&nbsp;</p><p>Adults and the elderly</p><p>Unless otherwise prescribed by your doctor, the normal dosage for the treatment of acute episodes of ulcerative colitis is:</p><p>1-2 sachets of Salofalk 1500&nbsp;mg granules once daily preferably in the morning (equivalent to 1.5-3g mesalazine per day) depending on the clinical requirements in the individual case.</p><p>&nbsp;</p><p><strong>To prevent a relapse of ulcerative colitis</strong></p><p>The normal dosage to prevent further episodes of ulcerative colitis is:</p><p>1 sachet of Salofalk 500mg granules three times daily (equivalent to 1.5g mesalazine per day).</p><p><strong>&nbsp;</strong></p><p>If upon the decision of your doctor you are at increased risk for recurrence, the dosage for prevention of further episodes of ulcerative colitis is:</p><p>2 sachets of Salofalk 1500&nbsp;mg granules once daily preferably in the morning (equivalent to 3g mesalazine per day).</p><p>&nbsp;</p><p><strong>Use in children</strong></p><p>There is only limited documentation for an effect in children (age 6-18 years).</p><p><u>&nbsp;</u></p><p><strong>Children 6 years of age and older</strong></p><p>Please ask your doctor about the precise dosage of Salofalk granules for your child.</p><p><strong>In acute episodes: </strong>to be determined individually, starting with 30-50 mg mesalazine per kg body weight per day that should be given once daily preferably in the morning or in&nbsp; divided doses. &nbsp;The maximum dose is 75 mg mesalazine per kg body weight per day. &nbsp;The total dose should not exceed the maximum adult dose.</p><p>It is generally recommended that half the adult dose should be given to children up to a body weight of 40 kg; and the normal adult dose to those above 40 kg.</p><p>Due to the high content of active substance, Salofalk 1500&nbsp;mg granules are not suitable for children weighing less than 40 kg. &nbsp;Please use Salofalk 500&nbsp;mg granules or 1000&nbsp;mg instead.</p><p>&nbsp;</p><p><strong>Duration of treatment</strong></p><p>Your doctor will decide how long you need to continue the treatment with this medicine. &nbsp;This will depend on your condition. To obtain the maximum benefit from this medicine, you should use Salofalk granules regularly and consistently both during the acute episode of inflammation and also as long-term treatment, as directed.</p><p>&nbsp;</p><p>If you think your Salofalk granules are too strong or too weak, talk to your doctor.</p><p>&nbsp;</p><p><strong>If you take more Salofalk granules than you should</strong></p><p>Contact a doctor if you are in doubt, so he or she can decide what to do.</p><p>If you use too much Salofalk granules on one occasion, just take your next dose as prescribed. Do not use a smaller amount.</p><p><strong>&nbsp;</strong></p><p><strong>If you forget to take Salofalk granules</strong></p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p><strong>If you stop taking Salofalk granules</strong></p><p>Do not stop taking this product until you have talked to your doctor.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&nbsp;</p><p>Like all medicines, Salofalk granules can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>All medicines can cause allergic reactions although serious allergic reactions are very rare. If you get any of the following symptoms after taking this medicine, you should contact your doctor immediately:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic skin rash</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Breathing difficulties</p><p>&nbsp;</p><p>If you experience a marked reduction of your general health, especially if accompanied by fever, and/or a sore throat and mouth, <u>stop using these granules and</u> contact your doctor immediately. These symptoms can, very rarely, be due to a fall in the number of white cells in your blood (a condition called agranulocytosis), which may make you more prone to developing a serious infection.</p><p>A blood test can confirm whether your symptoms are due to an effect of this medicine on your blood.</p><p>&nbsp;</p><p>Stop using mesalazine and seek medical attention immediately if you notice any of the following symptoms:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; reddish non-elevated, target-like or circular patches on the trunk, often with central blisters, skin peeling, ulcers of mouth, throat, nose, genitals and eyes, widespread rash, fever and enlarged lymph nodes. These serious skin rashes can be preceded by fever and flu-like symptoms.</p><p>&nbsp;</p><p>The following side effects have also been reported by patients using mesalazine:</p><p>&nbsp;</p><p><strong>Common side effects (may affect up to 1 in 10 people)</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p><strong>&nbsp;</strong></p><p><strong>Uncommon side effects (may affect up to 1 in 100 people)</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abdominal pain, diarrhoea, dyspepsia, wind (flatulence), nausea and vomiting</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe abdominal pain because of acute inflammation of the pancreas</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in liver function parameters, changes in pancreatic enzymes</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in the number of white blood cells</p><p><strong>&nbsp;</strong></p><p><strong>Rare side effects (may affect up to 1 in 1,000 people)</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dizziness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chest pain, breathlessness or swollen limbs because of an effect on your heart</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Jaundice or abdominal pain because of liver and bile flow disorders</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased sensitivity of your skin to sun and ultraviolet light (photosensitivity)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Joint pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling weak or tired</p><p><strong>&nbsp;</strong></p><p><strong>Very rare side effects (may affect up to 1 in 10,000 people)</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fever, sore throat or malaise, due to blood count changes</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Skin rash or inflammation, allergic condition which causes joint pain, skin rashes and fever</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe diarrhoea and abdominal pain because of an allergic reaction to this medicine within the bowel</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Numbness and tingling in the hands and feet (peripheral neuropathy)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shortness of breath, cough, wheezing, lung shadow on x-ray due to allergic and/or inflammatory lung conditions</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hair loss and the development of baldness</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Muscle pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes in kidney function, sometimes with swollen limbs or flank pain</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reversible decrease in semen production</p><p><s>&nbsp;</s></p><p>Not known (frequency cannot be estimated from the available data)</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kidney stones and associated kidney pain (see also section&nbsp;2)</p><p>&nbsp;</p><p>&nbsp;</p><p>Reporting of side effects</p><p>&nbsp;</p><p>If you get any side effects, talk to your doctor or pharmacist. &nbsp;This includes any possible side effects not listed in this leaflet.</p><p>&nbsp;</p><p>By reporting side effects you can help provide more information on the safety of this medicine</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>&nbsp;</p><p>Do not use Salofalk granules<sup> </sup>after the expiry date which is stated on the carton and the sachet after EXP. &nbsp;The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Do not store above 30 &deg;C.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away &nbsp;medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>What Salofalk 1500&nbsp;mg granules contain</strong></p><p>The active substance is<sup> </sup>mesalazine and one sachet of Salofalk 1500&nbsp;mg granules contains 1.5g mesalazine.</p><p>&nbsp;</p><p>The other ingredients are aspartame (E 951); carmellose sodium; cellulose, microcrystalline; citric acid; silica, colloidal anhydrous; hypromellose; magnesium stearate; methacrylic acid-methyl methacrylate copolymer (1:1) (Eudragit L 100); methylcellulose; polyacrylate dispersion 40&nbsp;% (Eudragit NE 40 D containing 2 % nonoxynol 100); povidone K 25; simeticone; sorbic acid; talc; titanium dioxide (E 171); triethyl citrate; vanilla custard flavour (containing sucrose).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Salofalk 1500 mg gastro-resistant prolonged-release granules are rod-shaped or round, grey-white granules.

Each sachet contains 2.79 g granules.

Salofalk 1500 mg granules are available in packs of 60sachets. 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Dr. Falk Pharma GmbH</p><p>Leinenweberstr. 5</p><p>79108 Freiburg</p><p>Germany</p><p>&nbsp;</p><p>Tel.: +49 (0) 761 / 1514-0</p><p>Fax: +49(0) 761 / 1514-321</p><p>E-mail: zentrale@drfalkpharma.de</p><p><em>&nbsp;</em></p><p>For more information, please contact your local agent. To find out the local agent for your country, please visit: http://www.drfalkpharma.com.</p><p>&nbsp;</p><p>Cigalah Group</p><p>Office 511, 5th floor, Aqaria Building 2,</p><p>Olaya St , Riyadh 11533, Saudi Arabia.</p><p>P.O.Box 50622</p><p>Tel: +966 11 4191471</p><p>Fax: +966 11 4191652</p><p>Email: info.reg@cigalah.com.sa</p><p>&nbsp;</p><p>To report any side effect(s):</p><p>The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>SFDA Call Center: 19999</p><p>Email: npc.drug@sfda.gov.sa</p><p>Website: www.sfda.gov.sa./npc</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>This is a Medicament</strong></p><p><strong>&nbsp;</strong></p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicament is a product which affects your health and its consumption contrary to instructions is dangerous for you.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Follow strictly the doctor&rsquo;s prescription, the method of use and the instructions of the pharmacist who sold the medicament.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The doctor and the pharmacist are the experts in medicines, their benefits and risks.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not by yourself interrupt the period of treatment prescribed for you.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not repeat the same prescription without consulting your doctor.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Keep all medicaments out of reach of children.</p><p>&nbsp;</p><p>Council of Arab Health Ministers</p><p>Union of Arab Pharmacists</p><p>&nbsp;</p><p>This patient information leaflet is approved by the Saudi Food and Drug Authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised: December 2022.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">تحتوي حبيبات سالوفالك على المادة الفعالة ميسالازين، وهي عامل مضاد للالتهاب يُستخدم لمعالجة داء الأمعاء الالتهابي.</p><p dir="RTL">تُستخدم حبيبات سالوفالك 1500 مجم في علاج:</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النوبات الحادة من التهابات الأمعاء الغليظة (القولون)، وهي ما تُعرف بين الأطباء باسم التهاب القولون التقرحي، ومنع حدوث مزيد من النوبات (تكرارها).</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تتناول حبيبات سالوفالك إذا</strong></p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من حساسية للميسالازين أو حمض الساليسيليك، أو الساليسيلات مثل الأسبرينAspirin &nbsp;أو لأي من المكونات الأخرى لهذا الدواء (انظر القسم 6)</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كنت تعاني من مرض كبدي أو كلوي خطير.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>التحذيرات والاحتياطات</strong></p><p dir="RTL"><strong>أخبر طبيبك قبل تناول </strong>حبيبات<strong> </strong>سالوفالك <strong>1500 مجم</strong></p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت في السابق من مشكلات في الرئتين، وعلى وجه التحديد إذا كنت تعاني من <strong>الربو</strong> <strong>الشُعبي </strong></p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت <strong>في السابق من</strong> <strong>حساسية للسلفاسالازين</strong>، وهي مادة مرتبطة بالميسالازين</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشكلات في <strong>الكبد</strong></p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشكلات في <strong>الكلى</strong></p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا سبق إصابتك بطفح جلدي شديد أو تقشر في الجلد، و/أو تقرحات و/ أو بثور في الفم بعد استخدام ميسالازين</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يسبب ميسالازين تغير لون البول إلى اللون الأحمر-البني بعد اتصاله مع مادة التبييض هيبوكلوريت الصوديوم في مياه المرحاض. هذا الأمر يتعلق بتفاعل كيميائي بين ميسالازين ومادة التبييض، وهو تفاعل غير ضار.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>احتياطيات إضافية</strong></p><p dir="RTL">أثناء فترة علاجك، قد يرغب طبيبك في وضعك قيد الملاحظة الطبية الدقيقة، وقد يُطلب منك إجراء تحاليل دم وبول بصفة منتظمة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">قد تتكون حصوات الكلى أثناء استخدام ميسالازين. وقد تتضمن الأعراض ألم على جانبي البطن، وظهور دم في البول. احرص على تناول كميات كافية من السوائل أثناء العلاج بميسالازين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم الإبلاغ عن حدوث تفاعلات جلدية خطيرة بما في ذلك تفاعلات دوائية مصحوبة بكثرة الخلايا اليوزينية وأعراض جهازية (DRESS)، متلازمة ستيفنز-جونسون (SJS)، وانحلال البشرة النخري السمي (TEN)، مع تلقي العلاج بميسالازين. توقف عن استخدام ميسالازين واطلب الرعاية الطبية على الفور إذا لاحظت أيًا من الأعراض المرتبطة بالتفاعلات الجلدية الخطيرة المذكورة في القسم 4.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأدوية الأخرى وحبيبات سالوفالك</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تتناول أو قد تناولت مؤخرًا أو ربما تتناول أي أدوية أخرى. وبصفة خاصة الأدوية التالية:</p><p dir="RTL">&nbsp;</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>بعض العوامل التي تثبط تجلط الدم </strong>(الأدوية المعالجة للتجلط أو المستخدمة للتقليل من لزوجة الدم، مثل وارفارين)</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>آزاثيوبرين، أو 6-مِركابتوبورين، أو ثيوجوانين</strong> (أدوية مُستخدمة في علاج اضطرابات<strong> </strong>المناعة)</p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>اللاكتوز</strong> (دواء مُستخدم لعلاج الإمساك) أو <strong>المستحضرات الأخرى التي قد تغير حموضة البراز</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يُرجى إخبار طبيبك أو الصيدلي إذا كنت تتناول أو قد تناولت مؤخرًا أي أدوية أخرى، بما في ذلك الأدوية التي يتم الحصول عليها دون وصفة طبية. قد يظل استمرارك في تناول حبيبات سالوفالك أمرًا مناسبًا، وسيكون طبيبك قادرًا على تحديد ما يتناسب معك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">إذا كنت حاملًا أو ترضعين رضاعة طبيعية أو تظنين أنك قد تكونين حاملًا أو تخططين لإنجاب طفل؛ فراجعي طبيبكِ أو الصيدلي للحصول على المشورة قبل استخدام هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب عدم استخدام أي حبيبات سالوفالك أثناء فترة الحمل إلا إذا طلب منك طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL">كما يجب أيضًا عدم استخدام حبيبات سالوفالك أثناء فترة الرضاعة الطبيعية إلا إذا سمح لكِ طبيبك بذلك، حيث إن هذا الدواء قد يُفرز في لبن الأم.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>القيادة واستخدام الآلات</strong></p><p dir="RTL">ليس لحبيبات سالوفالك أي تأثير على القدرة على القيادة واستخدام الآلات، أو تأثيرها يكاد لا يُذكر.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تحتوي حبيبات سالوفالك 1500 مجم على الأسبارتام، والسكروز، والصوديوم</strong></p><p dir="RTL">يحتوي هذا الدواء على 3 مجم من الأسبارتام في كل كيس من حبيبات سالوفالك 1500 مجم. يُعتبر الأسبارتام مصدرًا للفينيل ألانين. وقد يكون ضارًا إذا كنت مصابًا بمرض بيلَة الفينيل كيتون (PKU). وهو اضطراب وراثي نادر يتراكم فيه الفينيل ألانين، لأن الجسم لا يمكنه أن يتخلص منه بشكل ملائم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أخبرك طبيبك بأنك لا تتحمل بعض السكريات، فتواصل مع طبيبك قبل تناول هذا المنتج الدوائي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي هذا الدواء على أقل من 1 ميلي مول من الصوديوم (23 مجم) في كل كيس، أي أنه يُعدّ &quot;خاليًا من الصوديوم&quot; تقريبًا</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيفية تناول حبيبات سالوفالك 1500 مجم</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">تناول حبيبات سالوفالك دائمًا كما أخبرك طبيبك بالضبط. تحقق من طبيبك أو الصيدلي إذا لم تكن متأكدًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>طريقة تعاطي الدواء</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">حبيبات سالوفالك مُعدَّة للاستخدام الفموي فقط.</p><p dir="RTL">يُحظر <strong>مضغ</strong> حبيبات<strong> </strong>سالوفالك ينبغي عليك تناول حبيبات سالوفالك بوضعها فوق اللسان مباشرةً ثم ابتلاعها مع ماء وفير دون مضغ.</p><p>&nbsp;</p><p dir="RTL"><strong>الجرعة</strong></p><p dir="RTL">&nbsp;</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:641px"><tbody><tr><td colspan="2" style="vertical-align:bottom"><p dir="RTL"><strong>العمر ووزن الجسم</strong></p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL"><strong>الجرعة الفردية</strong></p></td><td style="vertical-align:bottom"><p dir="RTL"><strong>الجرعة اليومية الإجمالية</strong></p></td></tr><tr><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:bottom"><p dir="RTL"><strong>البالغون والكبار والأطفال</strong></p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:bottom"><p dir="RTL"><strong>الذين تتجاوز أوزانهم 40 كجم</strong></p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">معالجة النوبات الحادة</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">حتى 2 كيس من حبيبات</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">مرة واحدة من 1 إلى 2 كيس</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">سالوفالك 1500 مجم</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">منع حدوث مزيد من النوبات</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">2 كيس من حبيبات</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">مرة واحدة 2 كيس</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">(للمرضى المعرضين لخطر متزايد لتكرار النوبة)</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">سالوفالك 1500 مجم</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td><td colspan="2" style="vertical-align:bottom"><p dir="RTL">&nbsp;</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>البالغون والكبار</strong></p><p dir="RTL">ما لم يصف طبيبك خلاف ذلك، فإن الجرعة الطبيعية <strong>لعلاج النوبات الحادة</strong> <strong>من التهاب القولون التقرحي </strong>هي:</p><p dir="RTL">من 1 إلى 2 كيس من حبيبات سالوفالك 1500 مجم مرة واحدة يوميًا ويُفضل تناولها في الصباح (ما يكافئ 1.5 إلى 3 جم من الميسالازين في اليوم) استنادًا إلى المتطلبات السريرية للحالة الفردية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>لمنع عودة التهاب القولون التقرحي</strong></p><p dir="RTL">تتمثل الجرعة العادية لمنع مزيد من نوبات التهاب القولون التقرحي في:</p><p dir="RTL">1 كيس من حبيبات سالوفالك 500 مجم ثلاث مرات يوميًا (ما يكافئ 1.5 جم من الميسالازين في اليوم).</p><p dir="RTL">&nbsp;</p><p dir="RTL">وإذا كنت معرضًا لخطر متزايد لتكرار النوبة بحسب قرار طبيبك، تكون الجرعة اللازمة لمنع مزيد من نوبات التهاب القولون التقرحي كما يلي:</p><p dir="RTL">2 كيس من حبيبات سالوفالك 1500 مجم مرة واحدة يوميًا ويُفضل تناولها في الصباح (ما يكافئ 3 جم من الميسالازين في اليوم).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاستخدام للأطفال</strong></p><p dir="RTL">ليس هناك سوى قدر محدود من التوثيقات حول التأثير على الأطفال (من عمر 6 إلى 18 سنة).</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الأطفال أعمار 6 سنوات فأكثر</strong></p><p dir="RTL">يُرجى التحدث إلى طبيبك حول الجرعة الدقيقة من حبيبات سالوفالك لطفلك.</p><p dir="RTL"><strong>في حالة النوبات الحادة</strong>: يتم تحديدها بشكلٍ فردي، حيث تبدأ من 30 إلى 50 مجم من الميسالازين لكل كجم من وزن الجسم في اليوم ينبغي تناولها مرة واحدة يوميًا ويُفضل في الصباح، أو يتم تناولها على جرعات مقسَّمة.</p><p dir="RTL">تبلغ جرعة الحد الأقصى 75 مجم من الميسالازين لكل كجم<strong> </strong>من وزن الجسم في اليوم. ينبغي ألا تتجاوز الجرعة الكلية الحد الأقصى لجرعة الشخص البالغ.</p><p dir="RTL">يُوصى بشكلٍ عام بإعطاء نصف جرعة الشخص البالغ للأطفال الذين تصل أوزان أجسامهم إلى 40 كجم؛ وينبغي إعطاء جرعة الشخص البالغ العادية إلى الأطفال الذين تتجاوز أوزانهم 40 كجم.</p><p dir="RTL">ونتيجة وجود المادة الفعالة بمحتوى مرتفع، لا تصلح حبيبات سالوفالك 1500 مجم للأطفال الذين تقل أوزانهم عن 40 كجم. يُرجى استخدام حبيبات سالوفالك 500 مجم أو 1000 مجم بدلًا من ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>فترة العلاج</strong></p><p dir="RTL">سوف يقرر طبيبك المدة التي ينبغي عليك خلالها الاستمرار في تناول هذا الدواء. وسوف يتوقف ذلك على طبيعة حالتك المرضية. للحصول على أقصى استفادة من هذا الدواء، يتعين عليك تعاطي حبيبات سالوفالك بانتظام وبشكلٍ متسق خلال كلٍ من نوبة الالتهاب الحادة وأيضًا كعلاج طويل الأمد، حسب التوجيهات.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تعتقد أن حبيبات سالوفالك قوية جدًا أو ضعيفة جدًا، يمكنك مراجعة طبيبك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال تناول كم أكبر مما ينبغي من حبيبات سالوفالك</strong></p><p dir="RTL">اتصل بأحد الأطباء إذا راودك شك؛ كي يقرر الطبيب ما يتعين عليك فعله.</p><p dir="RTL">إذا تناولت حبيبات سالوفالك بكمية كبيرة مفرطة خلال مرةٍ واحدة، فتناول الجرعة التالية طبقًا للوصفة الطبية.</p><p dir="RTL">لا تتناول كمية أقل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال نسيان تناول حبيبات سالوفالك</strong></p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض جرعة منسية.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال التوقف عن تناول حبيبات سالوفالك</strong></p><p dir="RTL">لا تتوقف عن تناول هذا المنتج حتى تتحدث مع طبيبك أولًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كانت لديك أي أسئلة أخرى حول استخدام هذا المنتج، فاسأل طبيبك أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">قد تتسبب حبيبات سالوفالك في آثار جانبية، مثل كل الأدوية؛ ومع ذلك فهي لا تصيب جميع الأشخاص.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>يمكن لجميع الأدوية أن تسبب حالات الحساسية على الرغم من أن حالات الحساسية الخطيرة نادرة الحدوث جدًا. وفي حال إصابتك بأي من الأعراض التالية بعد تناول هذا الدواء، يجب عليك إبلاغ طبيبك على الفور:</strong></p><ul><li dir="RTL"><strong>طفح جلدي أرجي </strong></li><li dir="RTL"><strong>حُمّى</strong></li><li dir="RTL"><strong>صعوبات في التنفس.</strong></li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">إذا أصبحت تعاني من انخفاضٍ ملحوظ في صحتك العامة، لا سيما إذا كان ذلك مصحوبًا بحُمى و/أو احتقان في الحلق والفم، <u>فتوقف عن استخدام هذه الحبيبات</u> واتصل بطبيبك على الفور.</p><p dir="RTL">يُمكن أن تحدث هذه الأعراض، نادرًا جدًا، بسبب انخفاض عدد الكريات البيضاء في دمك (حالة مرضية تُدعى ندرة المُحببات)، والذي قد يجعلك أكثر عرضةً للإصابة بعدوى خطيرة.</p><p dir="RTL">يمكن إجراء اختبار دم لتحديد ما إن كانت هذه الأعراض بسبب تأثير هذا الدواء في دمك أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">توقف عن استخدام ميسالازين واطلب الرعاية الطبية على الفور إذا لاحظت أيًا من الأعراض التالية:</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; بقع حمراء غير منتفخة دائرية أو تشبه الهدف على الجذع، مع ظهور بثور في مركزها غالبًا، أو تقشر في الجلد، أو تقرحات في الفم، والحلق، والأنف، والأعضاء التناسلية والعينين، وطفح جلدي منتشر على نطاق واسع، والحمى، وتضخم العقد اللِمفيَّة. يمكن أن يسبق ظهور أشكال الطفح الجلدي الشديد هذه الحمى وأعراض تشبه أعراض الإنفلونزا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تم الإبلاغ أيضًا عن الآثار الجانبية التالية من قبل مرضى يستخدمون الميسالازين:</p><p dir="RTL"><strong>آثار جانبية شائعة </strong><strong>(</strong><strong>قد تصيب ما يصل إلى </strong><strong>1 </strong><strong>من بين كل </strong><strong>10 </strong><strong>أشخاص</strong><strong>)</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية غير شائعة (قد تصيب ما يصل إلى 1 من بين كل 100 شخص)</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم في البطن، وإسهال، وعسر هضم، وغازات (انتفاخ)، وغثيان، وقيء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم شديد بالبطن نتيجة لالتهاب حاد بالبنكرياس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في مؤشرات وظائف الكبد، تغيرات في قيم إنزيمات البنكرياس</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في عدد خلايا الدم البيضاء</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية نادرة </strong><strong>(</strong><strong>قد تصيب ما يصل إلى </strong><strong>1 </strong><strong>من بين كل </strong><strong>1000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدوار</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالصدر، انقطاع النفس أو تورم الأطراف نتيجة لحدوث تأثير على قلبك</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اليرقان أو ألم البطن بسبب اضطرابات في الكبد وتدفق الصفراء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية الزائدة لجلدك تجاه الشمس والأشعة فوق البنفسجية (التحسس الضوئي)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم المفاصل</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالضعف أو الإرهاق</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>آثار جانبية نادرة جدًا </strong><strong>(</strong><strong>قد تصيب ما يصل إلى </strong><strong>1 </strong><strong>من بين كل </strong><strong>10000 </strong><strong>شخص</strong><strong>)</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحمى، أو احتقان بالحلق، أو توعك نتيجة لتغيرات في تعداد خلايا الدم</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي أو التهاب، حالة تفاعل تحسسي تسبب ألم المفاصل، الطفح الجلدي والحمى</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إسهال شديد وألم بالبطن نتيجة لتفاعلات تحسسية داخل الأمعاء تجاه هذا الدواء</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خدر ووخز في اليدين والقدمين (اعتلال الأعصاب الطرفية)</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق التنفس، السعال، الأزيز، ظهور ظلال في الرئة في الأشعة السينية نتيجة لحالات حساسية و/أو التهابية بالرئة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سقوط الشعر والإصابة بالصلع</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالعضلات</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في وظائف الكلى، ويصحب ذلك أحيانًا تورم الأطراف أو ألم بالخاصرة</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض قابل للانعكاس في إنتاج المني</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>غير معروف (لا يمكن تقدير معدل التكرار من البيانات المتاحة)</strong></p><p dir="RTL">&ndash;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حصوات الكلى وألم الكلى المصاحب لها (انظر أيضا القسم 2)</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الآثار الجانبية</strong></p><p dir="RTL">إذا تعرضت لأي آثار جانبية، فراجع طبيبك أو الصيدلي. وهذا يشمل أي آثار جانبية مُحتملة غير مُدرجة في هذه النشرة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p>لا شك أن إبلاغك عن الآثار الجانبية سيساعد في تقديم المزيد من المعلومات حول سلامة هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيفية تخزين حبيبات سالوفالك 1500 مجم</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL">يُحفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تُستخدم حبيبات سالوفالك بعد تاريخ انتهاء الصلاحية المذكور على العبوة والكيس بعد الرمز &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا يُحفظ في درجة حرارة أعلى من 30 درجة مئوية.</p><p dir="RTL">لا تتخلص من أي أدوية ضمن مياه الصرف الصحي أو المخلفات المنزلية. استشر الصيدلي حول كيفية التخلص من الأدوية التي لم تعد تستخدمها. فهذه الإجراءات من شأنها المساعدة في حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>على ماذا تحتوي حبيبات سالوفالك 1500 مجم</strong></p><p dir="RTL">المادة الفعالة هي الميسالازين، حيث يحتوي الكيس الواحد من حبيبات سالوفالك 1500 مجم على 1.5 جم من الميسالازين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي الأسبارتام (E 951)؛ كارميلوز الصوديوم؛ سيلولوز بلوري مكروي؛ حمض الستريك؛ السيليكا الغروانية اللا مائية؛ هيبروميلوز؛ ستيارات المغنيزيوم؛ بلمر مشترك من حمض الميثاكريليك وميثاكريلات الميثيل (1:1) (Eudragit L 100)؛ ميثيل السيلولوز؛ مبعثر البولي أكريلات 40% (Eudragit NE 40 D يحتوي على 2% نونوكسينول 100)؛ بوفيدون K 25؛ سيميتيكون؛ حمض السوربيك؛ التلك؛ ثاني أكسيد التيتانيوم (E 171)؛ سترات ثلاثي الإيثيل؛ نكهة كاسترد الفانيليا (التي تحتوي على السكروز).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شكل حبيبات سالوفالك 1500 مجم ومحتويات العبوة</strong></p><p dir="RTL">حبيبات سالوفالك 1500 مجم هي حبيبات مقاومة للعصارة الهضمية وممتدة المفعول، عصوية أو مستديرة الشكل، وذات لون أبيض إلى رمادي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يحتوي كل كيس على حبيبات بوزن 2.79 جم.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تتوفر حبيبات سالوفالك 1500 مجم في عبوات تضم و60 كيس.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&nbsp;</p><p dir="RTL">Dr. Falk Pharma GmbH</p><p>Leinenweberstr. 5</p><p>79108 Freiburg</p><p dir="RTL">ألمانيا</p><p dir="RTL">&nbsp;</p><p dir="RTL">هاتف: +49 (0) 761/1514-0</p><p dir="RTL">فاكس: +49 (0) 761/1514-321</p><p dir="RTL">البريد الإلكتروني: zentrale@drfalkpharma.de</p><p dir="RTL">&nbsp;</p><p dir="RTL">لمزيد من المعلومات يرجى التواصل مع الوكيل المحلي لبلدكم,</p><p dir="RTL">لمعرفة الوكيل المحلي لبلدكم يرجي زيارة http://www.drfalkpharma.com</p><p dir="RTL">&nbsp;</p><p>مؤسسات سقالة</p><p>مكتب 511 , الدور الخامس, مبنى العقارية الثانية,</p><p>شارع العليا العام, الرياض 11533 , المملكة العربية السعودية.</p><p>صندوق بريد50622</p><p>+966 11 4191471 : تليفون</p><p>&nbsp;+966 114191652 : فاكس</p><p>info.reg@cigalah.com.sa: إيميل</p><p dir="RTL">&nbsp;</p><p dir="RTL">للإبلاغ عن الآثار الجانبية:</p><p dir="RTL">المركز الوطني للتيقظ والسلامة الدوائية (NPC)</p><p dir="RTL">مركز اتصال الهيئة العامة للغذاء والدواء: 19999</p><p dir="RTL">البريد الإلكترونيnpc.drug@sfda.gov.sa &nbsp;:</p><p dir="RTL">الموقع الإلكترونيwww.sfda.gov.sa/npc :</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>هذا المنتج دواء</strong></p><p><strong>&nbsp;</strong></p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الدواء منتج يؤثر في صحتك، واستهلاكه بما يخالف التعليمات يعرضك للخطر.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتبع بدقة وصفة الطبيب، وطريقة الاستخدام، وتعليمات الصيدلي الذي باع لك الدواء.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الطبيب والصيدلي هما الخبيران بالأدوية، وفوائدها، ومخاطرها.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تقطع فترة العلاج الموصوفة لك من تلقاء نفسك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تكرر الوصفة نفسها دون استشارة طبيبك.</p><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ بجميع الأدوية بعيدًا عن متناول الأطفال.</p><p><strong>&nbsp;</strong></p><p dir="RTL">مجلس وزراء الصحة العرب</p><p dir="RTL">اتحاد الصيادلة العرب</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">نشرة معلومات المريض هذه معتمدة من الهيئة العامة للغذاء والدواء السعودية.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم آخر تعديل لمعلومات الاستخدام هذه في ديسمبر.2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
Salofalk® 1500 mg gastro-resistant prolonged-release granules 


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each sachet of Salofalk® 1500 mg contains 1.5 g mesalazine.
Excipients with known effect: 
Each sachet of Salofalk® 1500 mg contains 3.0 mg aspartame and 0.12 mg sucrose.
For a full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gastro-resistant prolonged-release granules

Description: stick-formed or round, greyish white granules.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For the treatment of acute episodes and the maintenance of remission of ulcerative colitis</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Posology:</u></p><p>&nbsp;</p><p><em>Adults and the elderly</em></p><p><u>For the treatment of acute episodes of ulcerative colitis:</u></p><p>&nbsp;</p><p>Once daily, 1 sachet of Salofalk<sup>&reg;</sup> 3000&nbsp;mg, 1-2 sachets of Salofalk<sup>&reg;</sup> 1500&nbsp;mg, 3 sachets of Salofalk<sup>&reg;</sup> 1000&nbsp;mg or 3 sachets of Salofalk<sup>&reg;</sup> 500&nbsp;mg (equivalent to 1.5-3.0&nbsp;g mesalazine daily) preferably to be taken in the morning according to the individual clinical requirement.</p><p>&nbsp;</p><p>It is also possible to take the prescribed daily dose in three divided doses (1 sachet of Salofalk<sup>&reg;</sup> 500&nbsp;mg 3 times daily or 1 sachet of Salofalk<sup>&reg;</sup> 1000&nbsp;mg 3 times daily) if this is more convenient to the patient.</p><p>&nbsp;</p><p><u>For the maintenance of remission of ulcerative colitis:</u></p><p>The standard treatment is 0.5&nbsp;g mesalazine 3 times daily (in the morning, at midday and in the evening) corresponding to a total dose of 1500&nbsp;mg mesalazine per day.</p><p>&nbsp;</p><p>For patients known to be at increased risk for relapse for medical reasons or due to difficulties to adhere to application of three daily doses, the dosing schedule can be adapted to 3.0 g mesalazine given as a single daily dose, preferably in the morning.</p><p><u>&nbsp;</u></p><p><em>Paediatric population:</em></p><p>There is only limited documentation for an effect in children (age 6-18 years).</p><p>&nbsp;</p><p><u>Children 6 years of age and older:</u></p><p>Active disease:<strong> </strong>To be determined individually, starting with 30-50 mg/kg bw/day once daily preferably in the morning or in divided doses. Maximum dose: 75&nbsp;mg/kg bw/day. The total dose should not exceed the maximum adult dose.</p><p>Maintenance treatment: To be determined individually, starting with 15-30 mg/kg bw/day in divided doses. The total dose should not exceed the recommended adult dose.</p><p>&nbsp;</p><p>It is generally recommended that half the adult dose may be given to children up to a body weight of 40 kg and the normal adult dose to those above 40 kg.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Method of administration</p><p>The contents of the sachets of Salofalk<sup>&reg;</sup> granules should not be chewed. The granules should be taken on the tongue and swallowed, without chewing, with plenty of liquid.</p><p>&nbsp;</p><p>Both in the treatment of acute inflammatory episodes and during long term treatment, Salofalk<sup>&reg;</sup> granules should be used on a regular basis and consistently in order to achieve the desired therapeutic effects.</p><p>&nbsp;</p><p>The duration of use is determined by the physician.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Salofalk® granules are contraindicated in patients with:
-	hypersensitivity to the active substance, to salicylates or to any of the excipients listed in section 6.1
- 	severe impairment of hepatic or renal function.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Blood tests (differential blood count; liver function parameters such as ALT or AST; serum creatinine) and urinary status (dip sticks) should be determined prior to and during treatment, at the discretion of the treating physician. As a guideline, follow-up tests are recommended 14 days after commencement of treatment, then a further two to three tests at intervals of 4 weeks.</p><p>&nbsp;</p><p>If the findings are normal, follow-up tests should be carried out every three months. If additional symptoms occur, these tests should be performed immediately.</p><p>&nbsp;</p><p>Caution is recommended in patients with impaired hepatic function.</p><p>&nbsp;</p><p>Salofalk<sup>&reg;</sup> granules should not be used in patients with impaired renal function. Mesalazine-induced renal toxicity should be considered if renal function deteriorates during treatment.</p><p>&nbsp;</p><p>Cases of nephrolithiasis have been reported with the use of mesalazine including stones with a 100% mesalazine content. It is recommended to ensure adequate fluid intake during treatment.</p><p>&nbsp;</p><p>Mesalazine may produce red-brown urine discoloration after contact with sodium hypochlorite bleach (e.g., in toilets cleaned with sodium hypochlorite contained in certain bleaches).</p><p>&nbsp;</p><p>Patients with pulmonary disease, in particular asthma, should be very carefully monitored during a course of treatment with Salofalk<sup>&reg; </sup>granules.</p><p>&nbsp;</p><p><u>Severe cutaneous adverse reactions</u></p><p>Severe cutaneous adverse reactions (SCARs), including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in association with mesalazine treatment.</p><p>Mesalazine should be discontinued, at the first appearance of signs and symptoms of severe skin reactions, such as skin rash, mucosal lesions, or any other sign of hypersensitivity.</p><p>&nbsp;</p><p>Patients with a history of adverse drug reactions to preparations containing sulfasalazine should be kept under close medical surveillance on commencement of a course of treatment with Salofalk<sup>&reg; </sup>granules. Should Salofalk<sup>&reg;</sup> granules cause acute intolerance reactions, such as abdominal cramps, acute abdominal pain, fever, severe headache and rash, therapy should be discontinued immediately.</p><p>&nbsp;</p><p>This medicine contains 1&nbsp;mg/2&nbsp;mg/3&nbsp;mg/6&nbsp;mg aspartame in each sachet of Salofalk<sup>&reg;</sup> 500&nbsp;mg/1000&nbsp;mg/1500&nbsp;mg/3000&nbsp;mg. Aspartame is a source of phenylalanine. It may be harmful in patients with phenylketonuria (PKU).</p><p>&nbsp;</p><p>Salofalk granules contain sucrose. Patients with rare hereditary problems of fructose intolerance, glucose galactose malabsorption or sucrase-isomaltase insufficiency should not take these medicines.</p><p>&nbsp;</p><p>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;mg) per sachet, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Specific interaction studies have not been performed.</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lactulose or similar preparations &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; possible reduction of mesalazine which lower stool pH&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; release from granules due to &nbsp;&nbsp; decreased pH caused by bacterial &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; metabolism of lactulose</p><p>&nbsp;</p><p>In patients who are concomitantly treated with azathioprine, 6-mercaptopurine or thioguanine, a possible increase in the myelosuppressive effects of azathioprine, 6-mercaptopurine or thioguanine should be taken into account.</p><p>There is weak evidence that mesalazine might decrease the anticoagulant effect of warfarin</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy </u></p><p>There are no adequate data on the use of Salofalk<sup>&reg;</sup> granules in pregnant women. However, data on a limited number of exposed pregnancies indicate no adverse effect of mesalazine on pregnancy or on the health of the foetus/newborn child. To date no other relevant epidemiologic data are available. In one single case after long-term use of high dose mesalazine (2-4 g/day, orally) during pregnancy, renal failure in a neonate was reported.</p><p>&nbsp;</p><p>Animal studies on oral mesalazine do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic/foetal development, parturition or postnatal development.</p><p>&nbsp;</p><p>Salofalk<sup>&reg;</sup> granules should only be used during pregnancy if the potential benefit outweighs the possible risk.</p><p>&nbsp;</p><p><u>Breastfeeding</u></p><p>N-acetyl-5-aminosalicylic acid and to a lesser degree mesalazine are excreted in breast milk. Only limited experience during lactation in women is available to date. Hypersensitivity reactions, like diarrhoea in the infant, can not be excluded. Therefore, Salofalk<sup>&reg;</sup> granules should only be used during breastfeeding if the potential benefit outweighs the possible risk. If the infant develops diarrhoea, the breastfeeding should be discontinued.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Salofalk granules have no influence or negligible influence on the ability to drive and use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <table border="1" cellspacing="0" cellpadding="0" style="width:652px"><tbody><tr><td rowspan="2" style="vertical-align:top"><p><strong>System organ class</strong></p></td><td colspan="5" style="vertical-align:top"><p><strong>Frequency according to MedDRA convention</strong></p></td><td style="vertical-align:top"><p><strong>&nbsp;</strong></p></td></tr><tr><td style="vertical-align:top"><p>Common</p><p>(&ge;&nbsp;1/100 to &lt;&nbsp;1/10)</p></td><td style="vertical-align:top"><p>Uncommon</p><p>(&ge;&nbsp;1/1,000 to &lt;&nbsp;1/100)</p></td><td style="vertical-align:top"><p><em>Rare</em></p><p><em>(</em>&sup3;<em>&nbsp;1/10,000 to &lt;&nbsp;1/1,000)</em></p></td><td style="vertical-align:top"><p><em>Very rare</em><br /><em>(&lt;&nbsp;1/10,000)</em></p></td><td colspan="2" style="vertical-align:top"><p><em>Not known</em></p><p><em>(cannot be estimated from the available data)</em></p></td></tr><tr><td style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Altered blood counts (aplastic anaemia, agranulocytosis, pancytopenia, neutropenia, leukopenia, thrombocytopenia)</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Nervous system disorders</p></td><td style="vertical-align:top"><p>Headache</p><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Dizziness</p></td><td style="vertical-align:top"><p>Peripheral neuropathy</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Cardiac disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Myocarditis,</p><p>pericarditis</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Allergic and fibrotic lung reactions (including dyspnoea, cough, bronchospasm, alveolitis, pulmonary eosinophilia, lung infiltration, pneumonitis)</p><p>&nbsp;</p><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Gastrointestinal disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Abdominal pain,</p><p>diarrhoea, dyspepsia, flatulence, nausea, vomiting, acute pancreatitis</p></td><td style="vertical-align:top"><p><em>&nbsp;</em></p></td><td style="vertical-align:top"><p><em>&nbsp;</em></p></td><td colspan="2" style="vertical-align:top"><p><em>&nbsp;</em></p></td></tr><tr><td style="vertical-align:top"><p>Renal and urinary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Impairment of renal function including acute and chronic interstitial nephritis and renal insufficiency</p></td><td colspan="2" style="vertical-align:top"><p>Nephrolithiasis*</p></td></tr><tr><td style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Photosensitivity</p></td><td style="vertical-align:top"><p>Alopecia</p></td><td colspan="2" style="vertical-align:top"><p>Drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)</p></td></tr><tr><td style="vertical-align:top"><p>Musculoskeletal and connective tissue disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Arthralgia</p></td><td style="vertical-align:top"><p>Myalgia</p><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Immune system disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions such as allergic exanthema, drug fever, lupus erythematosus syndrome, pancolitis</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Hepatobiliary disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Cholestatic hepatitis</p></td><td style="vertical-align:top"><p>Hepatitis</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Reproductive system and breast disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Oligospermia (reversible)</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>General disorders</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Asthenia, fatigue</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr><tr><td style="vertical-align:top"><p>Investigations</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Changes in liver function parameters (increase in transaminases and parameters of cholestasis), changes in pancreatic enzymes (lipase and amylase increased), eosinophil count increased</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>&nbsp;</p></td><td colspan="2" style="vertical-align:top"><p>&nbsp;</p></td></tr></tbody></table><p>* see section&nbsp;4.4 for further information</p><p><em>&nbsp;</em></p><p>Severe cutaneous adverse reactions (SCARs), including drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), have been reported in association with mesalazine treatment (see section 4.4).</p><p><em>&nbsp;</em></p><p><u>Photosensitivity </u></p><p>More severe reactions are reported in patients with pre-existing skin conditions such as atopic dermatitis and atopic eczema.</p><p><em>&nbsp;</em></p><p><u>Reporting of suspected adverse reactions:</u></p><p>Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions to</p><p>&nbsp;</p><p>The National Pharmacovigilance Cetre (NPC):</p><p>SFDA Call Center: 19999</p><p>E-mail: npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are rare data on overdosage (e.g. intended suicide with high oral doses of mesalazine), which do not indicate renal or hepatic toxicity. There is no specific antidote and treatment is symptomatic and supportive.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Intestinal antiinflammatory agents; Aminosalicylic acid and similar agents</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; ATC code: A07EC02</p><p>&nbsp;</p><p>Mechanism of action</p><p>The mechanism of the anti-inflammatory action is unknown. The results of in vitro studies indicate that inhibition of lipoxygenase may play a role.</p><p>Effects on prostaglandin concentrations in the intestinal mucosa have also been demonstrated. Mesalazine (5-aminosalicylic acid / 5-ASA) may also function as a radical scavenger of reactive oxygen compounds.</p><p>&nbsp;</p><p>Pharmacodynamic effects</p><p>Mesalazine, orally administered, acts predominantly locally at the gut mucosa and in the submucosal tissue from the luminal side of the intestine. It is important, therefore, that mesalazine is available at the regions of inflammation. Systemic bioavailability/plasma concentrations of mesalazine are therefore of no relevance for therapeutic efficacy, but rather a factor for safety. In order to realise this, Salofalk<sup>&reg;</sup> granules are gastric juice resistant and release mesalazine in a pH dependent manner, due to an Eudragit L coating, and prolonged manner, due to the matrix granule structure.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>General considerations of mesalazine</u></p><p>&nbsp;</p><p><em>Absorption</em></p><p>Mesalazine absorption is highest in proximal and lowest in distal gut areas.</p><p>&nbsp;</p><p><em>Biotransformation</em></p><p>Mesalazine is metabolised both pre-systemically by the intestinal mucosa and the liver to the pharmacologically inactive N-acetyl-5-aminosalicylic acid (N-Ac-5-ASA). The acetylation seems to be independent of the acetylator phenotype of the patient. Some acetylation also occurs through the action of colonic bacteria. Protein binding of mesalazine and N-Ac-5-ASA is 43 % and 78 %, respectively.</p><p>&nbsp;</p><p><em>Elimination</em></p><p>Mesalazine and its metabolite N-Ac-5-ASA are eliminated via the faeces (major part), renally (varies between 20 and 50 %, depending on the kind of application, pharmaceutical preparation and route of mesalazine release, respectively), and biliary (minor part). Renal excretion predominantly occurs as N-Ac-5-ASA. About 1 % of the total orally administered mesalazine dose is excreted into the breast milk mainly as N-Ac-5-ASA.</p><p>&nbsp;</p><p><u>Salofalk<sup>&reg;</sup> Granules specific</u></p><p>&nbsp;</p><p><em>Distribution</em></p><p>Owing to the granule size of approx. 1 mm, transit from the stomach to the small intestine is fast.</p><p>A combined pharmacoscintigraphic/pharmacokinetic study showed that the compound reaches the ileocaecal region within approx. 3 hours and the ascending colon within approx. 4 hours. The total transit time in the colon amounts to about 20 hours.</p><p>Approximately 80 % of an administered oral dose is estimated to be available in the colon, sigmoid colon and rectum.</p><p>&nbsp;</p><p><em>Absorption</em></p><p>Mesalazine release from Salofalk<sup>&reg;</sup> granules starts after a lag phase of about 2-3 hours. Peak plasma concentrations are reached at about 4-5 hours. The systemic bioavailability of mesalazine after oral administration is estimated to be approximately 15-25 %.</p><p>Food intake delays absorption by 1 to 2 hours but does not change the rate and extent of absorption.</p><p>&nbsp;</p><p><em>Elimination</em></p><p>From a 3 x 500 mg daily mesalazine dose in long-term therapy, a total renal elimination of mesalazine and N-Ac-5-ASA under steady state conditions was calculated to be about 25 %. The unmetabolised excreted mesalazine part was less than 1 % of the oral dose. The elimination half-life in this study was 4.4 hours.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Preclinical data reveal no special hazard for humans based on conventional studies of safety pharmacology, genotoxicity, carcinogenicity (rat) or toxicity to reproduction.</p><p>&nbsp;</p><p>Kidney toxicity (renal papillary necrosis and epithelial damage in the proximal convoluted tubule or the whole nephron) has been seen in repeat-dose toxicity studies with high oral doses of mesalazine. The clinical relevance of this finding is unknown.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>List of excipients</strong></p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aspartame (E 951)</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carmellose sodium</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Citric acid</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Silica, colloidal anhydrous</p><p>5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hypromellose</p><p>6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Magnesium stearate</p><p>7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methacrylic acid-methyl methacrylate copolymer (1:1) (MW approx. 135000) (Eudragit L 100),</p><p>8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Methylcellulose</p><p>9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cellulose, microcrystalline</p><p>10.&nbsp; Polyacrylate dispersion 40 % (Eudragit NE 40 D containing 2 % Nonoxynol 100)</p><p>11.&nbsp; Povidone K 25</p><p>12.&nbsp; Simeticone</p><p>13.&nbsp; Sorbic acid</p><p>14.&nbsp; Talc</p><p>15.&nbsp; Titanium dioxide (E 171)</p><p>16.&nbsp; Triethyl citrate</p><p>17.&nbsp; Vanilla custard flavouring (containing sucrose</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                4 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 30 &deg;C.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Each sachet of Salofalk<sup>&reg;</sup> 1500&nbsp;mg contains 2.79&nbsp;g granules.</p><p>Pack sizes:</p><p>60 sachets Salofalk<sup>&reg; </sup>1500&nbsp;mg.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                DR. FALK PHARMA GmbH
Leinenweberstr. 5
79108 Freiburg
Germany
Tel.: +49 (0)761 1514-0
Fax: +49 (0)761 1514-321
E-mail: zentrale@drfalkpharma.de

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                December 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>